ＢＲＡＮＵ announced after the close on the 11th that it had raised its full-year forecast for the fiscal year ending October 2026, projecting revenue of ¥2.955 billion, operating profit of ¥469 million, ordinary profit of ¥452 million and net profit of ¥292 million. Following the announcement, buy orders have continued to queue for the shares.
ＢＲＡＮＵ revised upward its full-year forecast for the fiscal year ending October 2026. New contracts for CAREECON and upselling exceeded expectations, while productivity gains in development and sales through the use of AI contributed to improved profit margins.
Supported by an increase in new contracts and growing DX demand from client companies, revenue is projected to rise 5.5% from the previous forecast to ¥2.955 billion, operating profit to increase 18.8% to ¥469 million, ordinary profit to rise 19.6% to ¥452 million and net profit to increase 12.0% to ¥292 million.
In trading following the announcement, buy orders queued at the limit-up price, drawing the attention of market participants. Market attention is expected to remain focused on the company’s trading trends, progress in new contracts and developments in DX demand.